ArticleBMC gastroenterology2026
A 7-cm inflection point: nonlinear association between maximum tumor diameter and capsular invasion risk after primary liver cancer resection.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCapsular invasion independently predicts poor prognosis after primary liver cancer (PLC). While maximum tumor diameter (MTD) informs staging systems, its potential nonlinear association with capsular invasion remains unquantified.
methodsThis retrospective cohort study analyzed 1,380 consecutive patients undergoing curative liver resection for primary liver cancer (2008-2025). Multivariable logistic regression and restricted cubic splines (RCS) were used to model the MTD-capsular invasion relationship, adjusting for demographics, comorbidities, laboratory indices, and tumor characteristics.
resultsMTD exhibited a significant nonlinear, threshold-dependent association with capsular invasion (likelihood ratio test P = 0.011). For tumors ≤ 7 cm, each 1-cm increase in MTD increased the odds of capsular invasion by 15.4% (adjusted odds ratio [aOR] = 1.154, 95% confidence interval [CI]: 1.029-1.296; P = 0.0147). Conversely, for tumors ≥ 7 cm, no significant association was observed (aOR = 0.926, 95% CI: 0.832-1.031; P = 0.162). Furthermore, the association remained robust across all clinical subgroups (all interaction P > 0.05) and was confirmed by multiple sensitivity analyses.
conclusionsThis study identifies a 7-cm inflection point in the association between maximum tumor diameter and capsular invasion risk for resectable primary liver cancer. The relationship is characterized by a progressive increase in risk below this threshold, which stabilizes for tumors larger than 7 cm. These hypothesis-generating findings question the prevailing linear size-risk assumptions and underscore the need for future validation using preoperative imaging and prospective studies with long-term follow-up to evaluate its impact on patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.